XCYTE Canadian Trademark Information

On Friday, March 8, 2002, a canadian trademark registration was filed for XCYTE by Xcyte Therapies, Inc. *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1133760. The current status of this trademark filing is Interruption of proceeding. The correspondent listed for XCYTE is CLARK WILSON LLP of *********, **********, ***** **** The XCYTE trademark is filed in the description of Chemicals used for medical purposes, namely reagents containing ligands, effector molecules and antibodies for scientific or medical research use; antibody-conjugated micro-beads and antibody-conjugated microspheres all for scientific and medical research use and for activation of immune system cells. , Medical and scientific research; medical and scientific research for the development and commercialization of cell-based therapeutic immune system stimulators and enhancers to treat cancer and infectious diseases; technical research and consultation services in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices; development of new products in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices for others; medical laboratory services; research and development for new immunotherapy products for others. , Medical services, namely medical patient consulting and treatment services; medical services, featuring cell-base therapeutic immune system stimulators and enhancers to treat cancer and infectious diseases; medical services, namely, collecting, processing and storing blood and cells of the immune system and tumor and infected cells for later scientific and medical research and for activation of immune system cells. , Pharmaceutical preparations and compositions for therapeutic use, namely, for expanding, selecting and deleting cells of the immune systems; pharmaceutical preparations and compositions for therapeutic use, namely, for activating cells of the immune systems; pharmaceutical preparations for use in the treatment of cancer, infectious diseases and immunodeficiencies; antibody-conjugated beads, antibody-conjugated micro-beads and antibody-conjugated microspheres for promoting a therapeutic effect on the body. , Vials to store antibody-conjugated beads, antibody-conjugated micro-beads, antibody-conjugated microspheres and blood; plastic bags for transmitting medical specimens; plastic bags for use in the taking, filtrating and separation of blood; magnetic cell separation devices comprised of magnets to separate antibody-conjugated beads, antibody-conjugated micro-beads and antibody-conjugated microspheres from cells and antibodies, all of the foregoing goods for medical purposes; therapeutic devices, namely, kits comprised of the foregoing goods and cell lines for therapeutic purposes, medical apparatus and instruments, namely, kits comprised of the foregoing goods and cell lines for medical research purposes. .